Latest Strategy Changes News

Page 38 of 1113
thl reports an 11% rise in underlying NPAT for H1 FY26 and sets a bullish FY26 guidance, underpinned by strategic divestments and cost efficiencies.
Victor Sage
Victor Sage
23 Feb 2026
Chorus Limited has reported a strong half-year performance driven by fibre broadband growth, operational efficiencies, and a return to profitability, while launching initiatives to boost digital inclusion.
Sophie Babbage
Sophie Babbage
23 Feb 2026
Genesis Energy has reported a record first-half normalised EBITDAF of NZ$307 million, underpinned by strong hydro inflows and portfolio flexibility, while announcing a $400 million equity raise to accelerate its renewable growth strategy.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Fisher & Paykel Healthcare has raised its full-year revenue and profit forecasts for FY26, buoyed by strong hospital product growth and favourable exchange rates, while navigating the complexities of a recent US Supreme Court tariff ruling.
Ada Torres
Ada Torres
23 Feb 2026
Perenti Limited reported steady half-year revenue of $1.73 billion with a 10.9% increase in net profit, underpinned by a $300 million Dalgaranga contract and growing drilling services in the US. The company also announced an unfranked interim dividend and a CEO transition underway.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Deal headlines and big drill hits shared the stage with a brutal sell-off in a handful of tiny raisings. The week’s biggest winners were backed by clear news; the biggest losers showed what happens when buyers vanish after a halt.
Logan Eniac
Logan Eniac
21 Feb 2026
Big gains hit wealth platforms while Zip swung the other way as early optimism didn’t stick. Dividends and buy-backs kept coming, but investors still punished stocks where the next step looks unclear.
Logan Eniac
Logan Eniac
21 Feb 2026
Small caps stole the spotlight, with a handful of stocks doubling on deal news and early-stage project updates. Large miners were steadier, but even they couldn’t fully escape the week’s sharp gap moves.
Logan Eniac
Logan Eniac
21 Feb 2026
Two capital raisings and one brutal reset set the tone, even as several companies posted clean growth or strong clinical updates. Radiopharmaceuticals kept delivering good news, but investors still punished supply-chain and cash needs fast.
Logan Eniac
Logan Eniac
21 Feb 2026
FortifAI’s funding and big claims around faster AI data processing drove the week’s loudest move, while two small caps jumped on price queries. Elsewhere, results season rewarded clear recurring revenue growth, but punished gaps where early buying didn’t stick.
Logan Eniac
Logan Eniac
21 Feb 2026
Novatti Group has been served a writ in Malaysia over disputed earn-out payments from its 2022 ATX acquisition, with a claim of approximately AUD 2.67 million. Despite the legal challenge, ATX’s financial performance remains on an upward trajectory.
Claire Turing
Claire Turing
20 Feb 2026
Cash Converters International Limited has announced the recommencement of its Dividend Reinvestment Plan (DRP) effective 20 February 2026, restoring shareholders’ ability to reinvest dividends into additional shares with favourable terms.
Claire Turing
Claire Turing
20 Feb 2026